As on Wednesday, Organogenesis Holdings Inc (NASDAQ: ORGO) got off with the flyer as it spiked 2.09% to $5.87, before settling in for the price of $5.75 at the close. Taking a more long-term approach, ORGO posted a 52-week range of $2.61-$7.08.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 1617.00%. This publicly-traded company’s shares outstanding now amounts to $126.91 million, simultaneously with a float of $59.06 million. The organization now has a market capitalization sitting at $744.97 million. At the time of writing, stock’s 50-day Moving Average stood at $4.96, while the 200-day Moving Average is $4.43.
Organogenesis Holdings Inc (ORGO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – Specialty & Generic industry. Organogenesis Holdings Inc’s current insider ownership accounts for 53.46%, in contrast to 54.13% institutional ownership. According to the most recent insider trade that took place on Dec 16 ’25, this organization’s Director sold 200,000 shares at the rate of 5.14, making the entire transaction reach 1,027,060 in total value, affecting insider ownership by 2,565,591.
Organogenesis Holdings Inc (ORGO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
Organogenesis Holdings Inc’s EPS increase for this current 12-month fiscal period is 1617.00% and is forecasted to reach 0.18 in the upcoming year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Let’s observe the current performance indicators for Organogenesis Holdings Inc (ORGO). It’s Quick Ratio in the last reported quarter now stands at 2.88. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.60.
In the same vein, ORGO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.10, a figure that is expected to reach 0.22 in the next quarter, and analysts are predicting that it will be 0.18 at the market close of one year from today.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Through scrutinizing the latest numbers posted by the [Organogenesis Holdings Inc, ORGO], it can be observed that its last 5-days Average volume of 1.71 million was better the volume of 1.46 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 95.30% While, its Average True Range was 72.84.
Raw Stochastic average of Organogenesis Holdings Inc (ORGO) in the period of the previous 100 days is set at 65.48%, which indicates a major fall in contrast to 97.31% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.24 that was lower than 0.27 volatility it exhibited in the past 100-days period.
